SB
UTHR icon

Suntrust Banks’s United Therapeutics UTHR Stock Holding History

Suntrust Banks’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-3,778
Closed -$541K – 1497
2016
Q4 		$541K Buy
+3,778
New +$482K ﹤0.01% 965
2014
Q3 		– Sell
-2,608
Closed -$229K – 1440
2014
Q2 		$229K Sell
2,608
-6,337
-71% -$609K ﹤0.01% 1313
2014
Q1 		$840K Buy
8,945
+70
+0.8% +$7.16K ﹤0.01% 1054
2013
Q4 		$1M Sell
8,875
-988
-10% -$89.1K ﹤0.01% 927
2013
Q3 		$776K Buy
9,863
+1,174
+14% +$85.8K ﹤0.01% 1020
2013
Q2 		$570K Buy
+8,689
New +$560K ﹤0.01% 1103

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Suntrust Banks's UTHR Position: Q1 2017 in Review

Suntrust Banks sold out of United Therapeutics (UTHR) in Q1 2017, closing a stake of 3,778 shares — an estimated $541K sold.

Suntrust Banks first reported a position in UTHR in Q2 2013 and held it in 6 quarters. The position peaked at $1M in Q4 2013. 411 funds tracked by Wall St. Rank hold UTHR as of Q1 2017.

  • Suntrust Banks reported no remaining United Therapeutics position as of Q1 2017 after selling out during the quarter.
  • Suntrust Banks sold 3,778 United Therapeutics shares in Q1 2017, an estimated $541K.
  • Suntrust Banks first reported a position in United Therapeutics in Q2 2013 and held it in 6 quarters.
  • Suntrust Banks's United Therapeutics position peaked at $1M in Q4 2013.
  • 411 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2017.

Based on Suntrust Banks's 13F filing for Q1 2017, filed 3 May 2017.